NCT00313508View on ClinicalTrials.gov

Dendritic Cell Vaccination During Lymphoid Reconstruction

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Intraocular MelanomaMelanoma (Skin)
Interventions
BIOLOGICAL

Autologous Dendritic Cells (DC)

Given intranodally

DRUG

Fludarabine

Fludarabine will be administered intravenously (IV) over 30 minutes, daily for 5 consecutive days.

BIOLOGICAL

Autologous Lymphocyte Infusion (ALI)

Infusion

Trial Locations (1)

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT00313508 - Dendritic Cell Vaccination During Lymphoid Reconstruction | Biotech Hunter | Biotech Hunter